Table 1

Clinical characteristics of the Danish ADDITON-PRO study population by glucose tolerance status

NGTi-IFGi-IGTIFG&IGTType 2 diabetes*P
N774287112126163
Age (years)65.7 (7.5)66.4 (6.9)68.2 (6.1)ab66.4 (6.2)c66.2 (6.5)c0.008
Women (%)51.9 (48.4; 55.5)37.6 (32.0; 43.5)a54.5 (44.8; 63.9)b45.2 (36.4; 54.3)33.7 (26.5; 41.6)acd<0.001
FHD (%)24.9 (21.9; 28.1)31.4 (26.0; 37.1)31.3 (22.8; 40.7)30.2 (22.3; 39.0)30.7 (23.7; 38.4)0.155
Height (cm)170.3 (9.4)172.1 (8.6)a168.5 (9.1)b169.2 (9.3)b171.7 (8.8)cd0.001
BMI (kg/m2)26.0 (4.0)27.7 (4.4)a27.4 (4.4)a28.8 (4.2)abc29.7 (5.6)abc<0.001
Waist circ. (cm)91.8 (12.1)98.1 (12.2)a96.1 (12.8)a100.6 (11.8)ac103.5 (14.0)abcd<0.001
HbA1c (%)5.6 (0.3)5.7 (0.4)a5.7 (0.3)a5.8 (0.3)ab6.1 (0.6)abcd<0.001
HbA1c (mmol/mol)43.0 (3.8)44.5 (4.2)a44.8 (4.1)a45.8 (3.8)ab49.8 (7.4)abcd<0.001
  • Data are means (SD) or percentages (95% CI). circ., circumference; FHD, family history of diabetes.

  • *Screen-detected type 2 diabetes.

  • aP < 0.05 vs. NGT;

  • bP < 0.05 vs. i-IFG;

  • cP < 0.05 vs. i-IGT;

  • dP < 0.05 vs. IFG&IGT.